Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Aug 28, 2013; 19(32): 5320-5325
Published online Aug 28, 2013. doi: 10.3748/wjg.v19.i32.5320
Published online Aug 28, 2013. doi: 10.3748/wjg.v19.i32.5320
Prevalence of hepatitis C infection among intravenous drug users in Shanghai
Yan-Lin Tao, Yu-Fan Tang, Xiao-Feng Cai, Xiao-Ting Shen, Ya-Xin Wang, Xue-Tao Zhao, Microbiology Laboratory, Center for Disease Control and Prevention of Xuhui, Shanghai 200237, China
Jian-Ping Qiu, Microbiology Laboratory, Shanghai Public Health Clinical Center, Shanghai 200083, China
Author contributions: Tao YL and Tang YF carried out the screening tests for antibodies to hepatitis C virus, Recombinant immunoblot assay, and Qualitative tests for hepatitis C virus RNA; Qiu JP, Cai XF, Shen XT and Wang YX participated in the screening tests for antibodies to hepatitis C virus and sample assembly; Zhao XT designed this study, performed the statistical analysis and wrote the paper; all authors read and approved the final manuscript.
Supported by Science and Technology Commission Xuhui District and Xuhui Health Bureau of Shanghai, No. SHXH201226
Correspondence to: Xue-Tao Zhao, MPH, Microbiology Laboratory, Center for Disease Control and Prevention of Xuhui, 50 Yongchuan Road, Xuhui District, Shanghai 200237, China. zhaoxtc@gmail.com
Telephone: +86-21-54012590 Fax: +86-21-54012590
Received: April 24, 2013
Revised: July 15, 2013
Accepted: July 18, 2013
Published online: August 28, 2013
Revised: July 15, 2013
Accepted: July 18, 2013
Published online: August 28, 2013
Core Tip
Core tip: In this report, we examined the prevalence of anti-hepatitis C virus (HCV) antibodies, as well as chronic viremia, in 432 intravenous drug users (IDUs) in Shanghai, China. Our data will facilitate the characterization of the prevalence of HCV infection among Chinese IDUs and will complement our understanding of the natural course of HCV infections.